Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer
Absztrakt Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, with clinical features of high metastatic potential, susceptibility to relapse, and poor prognosis. TNBC lacks the expression of the estrogen receptor (ER), progesterone receptor (PR), and human…